Serum leptin in obesity is related to gender and body fat topography but does not predict successful weight loss

Department of Clinical Nutrition, University of Kuopio, Finland.

OBJECTIVE: Leptin is the product of the ob gene shown to regulate body fat and appetite in mice. It is produced by human adipose tissue also, but its physiological functions in man are poorly known. STUDY DESIGN AND METHODS: We studied serum leptin concentrations in ten obese men and 35 obese women (age and body mass index 42 +/- 7 years and 35.1 +/- 3.6 kg/m2 respectively) before (baseline) and at 17 and 57 weeks during weight loss of 10.9% of the initial weight. RESULTS: Serum leptin concentrations at baseline were 55% higher in women than in men (after adjustment for age and body fat mass, P = 0.002) and remained so during the follow-up. At baseline, serum leptin correlated with fat mass (r = 0.60, P < 0.001) estimated by bioelectrical impedance, and the changes in leptin concentrations from baseline to week 17 correlated with the changes in fat mass (r = 0.73, P < 0.001), but baseline leptin levels were not predictive of the successful weight loss. Leptin concentrations correlated with hip circumference (r = 0.49, P < 0.001 at baseline adjusted for age and sex), but the correlation with waist circumference became evident only during the weight loss (at week 57, r = 0.63, P < 0.001). CONCLUSIONS: Serum leptin concentrations are higher in obese women than in obese men before and during weight loss, but the topography of fat tissue influences serum leptin concentrations. Serum leptin concentrations do not predict the response to weight reduction.

This article has been cited by other articles:

				C. Langenberg, J. Bergstrom, G. A. Laughlin, and E. Barrett-Connor Ghrelin, Adiponectin, and Leptin Do Not Predict Long-term Changes in Weight and Body Mass Index in Older Adults: Longitudinal Analysis of the Rancho Bernardo Cohort Am. J. Epidemiol., December 15, 2005; 162(12): 1189 - 1197. [Abstract] [Full Text] [PDF]

				A. M. Rodrigues, R. B. Radominski, H. d. L. Suplicy, S. M. De Almeida, P. A. Niclewicz, and C. L. Boguszewski The Cerebrospinal Fluid/Serum Leptin Ratio during Pharmacological Therapy for Obesity J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1621 - 1626. [Abstract] [Full Text] [PDF]

				A. W. Hsing, S. Chua Jr, Y.-T. Gao, E. Gentzschein, L. Chang, J. Deng, and F. Z. Stanczyk Prostate Cancer Risk and Serum Levels of Insulin and Leptin: a Population-Based Study J Natl Cancer Inst, May 16, 2001; 93(10): 783 - 789. [Abstract] [Full Text] [PDF]

				R. Lucantoni, E. Ponti, M. E. Berselli, G. Savia, A. Minocci, G. Calò, C. De Medici, A. Liuzzi, and A. M. Di Blasio The A19G Polymorphism in the 5' Untranslated Region of the Human Obese Gene Does Not Affect Leptin Levels in Severely Obese Patients J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3589 - 3591. [Abstract] [Full Text]

				P. S. Duggal, K. H. Van der Hoek, C. R. Milner, N. K. Ryan, D. T. Armstrong, D. A. Magoffin, and R. J. Norman The in Vivo and in Vitro Effects of Exogenous Leptin on Ovulation in the Rat Endocrinology, June 1, 2000; 141(6): 1971 - 1976. [Abstract] [Full Text] [PDF]

				S. Klein, J. F. Horowitz, M. Landt, S. J. Goodrick, V. Mohamed-Ali, and S. W. Coppack Leptin production during early starvation in lean and obese women Am J Physiol Endocrinol Metab, February 1, 2000; 278(2): E280 - E284. [Abstract] [Full Text] [PDF]

				J. S. Torgerson, B. Carlsson, K. Stenlöf, L. M. S. Carlsson, E. Bringman, and L. Sjöström A Low Serum Leptin Level at Baseline and a Large Early Decline in Leptin Predict a Large 1-Year Weight Reduction in Energy-Restricted Obese Humans J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4197 - 4203. [Abstract] [Full Text]

				B. E Wisse, L A. Campfield, E. B Marliss, J. A Morais, R. Tenenbaum, and R. Gougeon Effect of prolonged moderate and severe energy restriction and refeeding on plasma leptin concentrations in obese women Am. J. Clinical Nutrition, September 1, 1999; 70(3): 321 - 330. [Abstract] [Full Text] [PDF]